TR200100107T2 - Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem. - Google Patents
Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem.Info
- Publication number
- TR200100107T2 TR200100107T2 TR2001/00107T TR200100107T TR200100107T2 TR 200100107 T2 TR200100107 T2 TR 200100107T2 TR 2001/00107 T TR2001/00107 T TR 2001/00107T TR 200100107 T TR200100107 T TR 200100107T TR 200100107 T2 TR200100107 T2 TR 200100107T2
- Authority
- TR
- Turkey
- Prior art keywords
- polymer
- pharmaceutical form
- active ingredient
- programmed
- preparation
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 2
- 229920000642 polymer Polymers 0.000 abstract 4
- 239000004480 active ingredient Substances 0.000 abstract 3
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 230000003111 delayed effect Effects 0.000 abstract 2
- 230000002496 gastric effect Effects 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Bulus, aktif bilesenin saliniminin gecikmeli ve fasilali oldugu ve farmasötik formun alinmasindan sonra 4 ila 8 saat içinde aktif bilesenin kullanilabilmesini saglayan, ve daha sonra takip eden 8 ila 20 saat içinde aktif bilesenin tümünün sürekli olarak salinmasini saglayan bulusa göre olan çok parçacikli farmasötik form ile ilgilidir, ki özelligi organik asit içermemesi, ve içinde aktif bileseni olusturan parçaciklarin esit olarak dagildigi en az bir hidro-çözünebilir polimer ve en az bir hidro-çözünebilir olmayan polimer karisimina dayanan bir birinci kaplama içeren bir nötr küresel çekirdek, gastrik ve intestinel ortamlara göre birbirinden farkli geçirgenlik hizlari saglayan en az iki pH bagimsiz polimere, en az bir pH bagimli polimere, en az bir plastiklestiriciye ve esit olarak dagilmis en az bir inert tasiyiciya dayanan bir ikinci kaplama içeren tibbi küreler formunda olmasidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9806384A FR2778848B1 (fr) | 1998-05-20 | 1998-05-20 | Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200100107T2 true TR200100107T2 (tr) | 2001-06-21 |
Family
ID=9526556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/00107T TR200100107T2 (tr) | 1998-05-20 | 1999-05-20 | Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem. |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1077687B1 (tr) |
JP (1) | JP2002515423A (tr) |
KR (1) | KR100583065B1 (tr) |
CN (1) | CN1186014C (tr) |
AT (1) | ATE214598T1 (tr) |
AU (1) | AU758299B2 (tr) |
BG (1) | BG64764B1 (tr) |
BR (1) | BR9910606A (tr) |
CA (1) | CA2333188C (tr) |
DE (1) | DE69901062T2 (tr) |
DK (1) | DK1077687T3 (tr) |
ES (1) | ES2173739T3 (tr) |
FR (1) | FR2778848B1 (tr) |
GE (1) | GEP20022750B (tr) |
HK (1) | HK1033271A1 (tr) |
HU (1) | HU224193B1 (tr) |
IL (1) | IL139774A (tr) |
MX (1) | MXPA00011364A (tr) |
NO (1) | NO330501B1 (tr) |
NZ (1) | NZ508392A (tr) |
PL (1) | PL192950B1 (tr) |
PT (1) | PT1077687E (tr) |
TR (1) | TR200100107T2 (tr) |
WO (1) | WO1999059557A1 (tr) |
ZA (1) | ZA200006768B (tr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
CA2529984C (en) | 2003-06-26 | 2012-09-25 | Isa Odidi | Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
NZ709754A (en) | 2004-10-21 | 2017-02-24 | Adare Pharmaceuticals Inc | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
AU2013273835B2 (en) * | 2005-05-02 | 2016-07-07 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
US9161918B2 (en) * | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
WO2008136016A1 (en) * | 2007-05-08 | 2008-11-13 | Medreich Limited | A stable controlled release oral solid dosage form composition and a process thereof |
MX2012006240A (es) | 2009-12-02 | 2012-10-03 | Aptalis Pharma Ltd | Microcapsulas de fexofenadina y composiciones que contienen las mismas. |
FR2999432B1 (fr) | 2012-12-17 | 2014-12-12 | Ethypharm Sa | Comprimes orodispersibles obtenus par compression moulage |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2558396B2 (ja) * | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | 放出制御型製剤 |
US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
FR2754710B1 (fr) * | 1996-10-22 | 1998-12-31 | Prographarm Lab | Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle |
-
1998
- 1998-05-20 FR FR9806384A patent/FR2778848B1/fr not_active Expired - Lifetime
-
1999
- 1999-05-20 PT PT99920897T patent/PT1077687E/pt unknown
- 1999-05-20 GE GEAP19995632A patent/GEP20022750B/en unknown
- 1999-05-20 EP EP99920897A patent/EP1077687B1/fr not_active Expired - Lifetime
- 1999-05-20 ES ES99920897T patent/ES2173739T3/es not_active Expired - Lifetime
- 1999-05-20 WO PCT/FR1999/001201 patent/WO1999059557A1/fr active IP Right Grant
- 1999-05-20 BR BR9910606-0A patent/BR9910606A/pt not_active Application Discontinuation
- 1999-05-20 JP JP2000549222A patent/JP2002515423A/ja active Pending
- 1999-05-20 HU HU0102027A patent/HU224193B1/hu active IP Right Grant
- 1999-05-20 IL IL13977499A patent/IL139774A/xx not_active IP Right Cessation
- 1999-05-20 MX MXPA00011364A patent/MXPA00011364A/es active IP Right Grant
- 1999-05-20 DE DE69901062T patent/DE69901062T2/de not_active Expired - Lifetime
- 1999-05-20 CN CNB998074322A patent/CN1186014C/zh not_active Expired - Lifetime
- 1999-05-20 TR TR2001/00107T patent/TR200100107T2/tr unknown
- 1999-05-20 KR KR1020007013020A patent/KR100583065B1/ko not_active IP Right Cessation
- 1999-05-20 CA CA2333188A patent/CA2333188C/fr not_active Expired - Lifetime
- 1999-05-20 AT AT99920897T patent/ATE214598T1/de active
- 1999-05-20 NZ NZ508392A patent/NZ508392A/xx not_active IP Right Cessation
- 1999-05-20 DK DK99920897T patent/DK1077687T3/da active
- 1999-05-20 PL PL344314A patent/PL192950B1/pl unknown
- 1999-05-20 AU AU38302/99A patent/AU758299B2/en not_active Expired
-
2000
- 2000-11-17 NO NO20005838A patent/NO330501B1/no not_active IP Right Cessation
- 2000-11-17 BG BG104963A patent/BG64764B1/bg unknown
- 2000-11-20 ZA ZA200006768A patent/ZA200006768B/en unknown
-
2001
- 2001-06-11 HK HK01103971A patent/HK1033271A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200100107T2 (tr) | Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem. | |
KR950702409A (ko) | 방출 조절 모르핀 제제(controlled release morphine preparation) | |
AU2001239658A1 (en) | Method for producing a controlled-release preparation | |
AU7495596A (en) | Process for the production of morphologically uniform microcapsules and microcapsules that are produced according to this process | |
EP1397200B1 (de) | Auflösbare nano- und mikrokapseln, verfahren zu ihrer herstellung sowie ihre verwendung | |
HUP0004732A2 (hu) | Kapszulázási eljárás | |
FR2775435B1 (fr) | Nanoparticules comprenant au moins un polymere et au moins un compose apte a complexer un ou plusieurs principes actifs | |
TR199901564T2 (tr) | Hizli çözülebilen ve tat-maskesi saglayan dozaj ispençiyari formu. | |
IS5577A (is) | Omeprazól örkorn vernduð gegn magasýrum, framleiðsluferli og lyfjasamsetningar | |
DE3850826T2 (de) | Polymere, nichtwässerige Dispersionen, Verfahren zu deren Herstellung und Beschichtungszusammensetzungen. | |
AU574220B2 (en) | Sustained release drug in ter polymer coat (pvc and pvacand pvom) | |
DE69526434D1 (de) | Metronidazolpräparate mit modifizierter freisetzung und verfahren für ihre herstellung und verwendung | |
DK1417960T3 (da) | Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf | |
CA2163539A1 (en) | N-morpholino-n-nitrosaminoacetonitrile cyclodextrin inclusion complexes | |
FR2791569B1 (fr) | Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention | |
ATE364403T1 (de) | Retardtablette hergestellt aus linearen wasserunlöslichen polysacchariden | |
ATE218371T1 (de) | Orale arzneiform enthaltend colestipol als träger mit sauren wirkstoffen und verfahren zu ihrer herstellung | |
HUP0202895A2 (hu) | Eljárás késleltetett hatóanyag-leadású komplexek előállítására | |
JPS5318646A (en) | Soil conditioner | |
HUP9901338A2 (hu) | Eljárás kinolon-karbonsavak vagy naftiridin-karbonsavak előállítására szabad bázis formájú alakban | |
CA2617351A1 (en) | Diltiazem controlled release formulation and method of manufacture | |
JPS5590517A (en) | Water-containing gel | |
ES2004693A6 (es) | Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo. | |
TH20029B (th) | ควิโนโลนคาร์บอกซิลิค แอซิดที่ถูกแทนที่ด้วย n-หมู่ใดๆ 6-ฟลูออโร-8-ไดฟลูออโรเมธอกซีที่เป็นสารชนิดใหม่ | |
KR970014762A (ko) | 하이드로겔을 사용한 매트릭스형 경피투여시스템 |